Hepatocellular carcinoma (HCC) is the most common type of liver cancer and its treatment options are determined by shape, liver function, loci, and stages of cancer. Diffuse type of infiltrative HCC accompanied by portal vein tumor thrombosis (PVTT) has the poorest prognosis among other HCCs and there are no other prominent treatment options than systemic chemotherapy. In this study, we report a case of a 56-year-old man with diffuse infiltrative HCC accompanied by PVTT who achieved complete remission for 8 years after receiving conventional transcatheter arterial chemoembolization using adriamycin and gelfoam
Introduction: We report a patient with a rapidly progressing recurrence of hepatocellular carcinoma ...
BackgroundPortal vein tumor thrombosis (PVTT) is a frequent complication of hepatocellular carcinoma...
Portal vein tumor thrombus (PVTT) is one of the common manifestations in patients with advanced hepa...
Hepatocellular carcinoma (HCC) is the sixth most common cause of death worldwide and the main cause ...
Hepatocellular carcinoma is a main challenge in oncologic care. Surgery is the mainstay of treatment...
Background Portal vein tumor thrombosis (PVTT) is a common complication of hepatocellular carcinoma ...
Prognosis of hepatocellular carcinoma (HCC) patients with tumor thrombi (TT) in the trunk of the por...
Prognosis of hepatocellular carcinoma (HCC) patients with tumor thrombi (TT) in the trunk of the por...
Portal vein tumor thrombosis (PVTT) often occurs in advanced hepatocellular carcinoma (HCC) patients...
AbstractIntroductionWe report a patient with a rapidly progressing recurrence of hepatocellular carc...
Hepatocellular carcinoma is the fourth leading cause of cancer worldwide, and the fastest increasing...
Hepatocellular carcinoma (HCC) is characterized by high morbidity, high recurrence, and high mortali...
We present a case of a 43-year-old man with advanced hepatocellular carcinoma (HCC) with portal vein...
Hepatocellular carcinoma (HCC) is the fifth commonest cancer worldwide. Vascular invasion of the por...
Transarterial chemoembolization (TACE) could achieve a better survival benefit than conservative tre...
Introduction: We report a patient with a rapidly progressing recurrence of hepatocellular carcinoma ...
BackgroundPortal vein tumor thrombosis (PVTT) is a frequent complication of hepatocellular carcinoma...
Portal vein tumor thrombus (PVTT) is one of the common manifestations in patients with advanced hepa...
Hepatocellular carcinoma (HCC) is the sixth most common cause of death worldwide and the main cause ...
Hepatocellular carcinoma is a main challenge in oncologic care. Surgery is the mainstay of treatment...
Background Portal vein tumor thrombosis (PVTT) is a common complication of hepatocellular carcinoma ...
Prognosis of hepatocellular carcinoma (HCC) patients with tumor thrombi (TT) in the trunk of the por...
Prognosis of hepatocellular carcinoma (HCC) patients with tumor thrombi (TT) in the trunk of the por...
Portal vein tumor thrombosis (PVTT) often occurs in advanced hepatocellular carcinoma (HCC) patients...
AbstractIntroductionWe report a patient with a rapidly progressing recurrence of hepatocellular carc...
Hepatocellular carcinoma is the fourth leading cause of cancer worldwide, and the fastest increasing...
Hepatocellular carcinoma (HCC) is characterized by high morbidity, high recurrence, and high mortali...
We present a case of a 43-year-old man with advanced hepatocellular carcinoma (HCC) with portal vein...
Hepatocellular carcinoma (HCC) is the fifth commonest cancer worldwide. Vascular invasion of the por...
Transarterial chemoembolization (TACE) could achieve a better survival benefit than conservative tre...
Introduction: We report a patient with a rapidly progressing recurrence of hepatocellular carcinoma ...
BackgroundPortal vein tumor thrombosis (PVTT) is a frequent complication of hepatocellular carcinoma...
Portal vein tumor thrombus (PVTT) is one of the common manifestations in patients with advanced hepa...